Title |
Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy.
|
---|---|
Published in |
JNCI: Journal of the National Cancer Institute, August 2020
|
DOI | 10.1093/jnci/djaa116 |
Pubmed ID | |
Authors |
Maria Alice Franzoi, Daniel Eiger, Lieveke Ameye, Noam Ponde, Rafael Caparica, Claudia De Angelis, Mariana Brandão, Christine Desmedt, Serena Di Cosimo, Nuria Kotecki, Matteo Lambertini, Ahmad Awada, Martine Piccart, Evandro de Azambuja |
X Demographics
The data shown below were collected from the profiles of 23 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Belgium | 5 | 22% |
United States | 2 | 9% |
Brazil | 2 | 9% |
Spain | 1 | 4% |
Switzerland | 1 | 4% |
Mexico | 1 | 4% |
Italy | 1 | 4% |
France | 1 | 4% |
Unknown | 9 | 39% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 12 | 52% |
Scientists | 7 | 30% |
Practitioners (doctors, other healthcare professionals) | 3 | 13% |
Science communicators (journalists, bloggers, editors) | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 45 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 4 | 9% |
Student > Ph. D. Student | 4 | 9% |
Other | 3 | 7% |
Student > Postgraduate | 2 | 4% |
Unspecified | 1 | 2% |
Other | 2 | 4% |
Unknown | 29 | 64% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 10 | 22% |
Nursing and Health Professions | 4 | 9% |
Biochemistry, Genetics and Molecular Biology | 1 | 2% |
Agricultural and Biological Sciences | 1 | 2% |
Unspecified | 1 | 2% |
Other | 0 | 0% |
Unknown | 28 | 62% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 January 2021.
All research outputs
#2,525,526
of 25,413,176 outputs
Outputs from JNCI: Journal of the National Cancer Institute
#1,653
of 7,850 outputs
Outputs of similar age
#66,871
of 426,989 outputs
Outputs of similar age from JNCI: Journal of the National Cancer Institute
#30
of 56 outputs
Altmetric has tracked 25,413,176 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,850 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 426,989 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.